Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENTIVE VT: Preventive Ablation in Ischemic Cardiomyopathy
NCT03421834Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Feb 2018
- Primary completion
- Jan 2024
- Countries
- 2
01
Overview
Randomised, open-label trial (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Time to first event comprising appropriate ICD therapy and unplanned hospital admission for symptomatic ventricular tachycardia (VT)/ ventricular fibrillation (VF) at 24 months. Started Feb 2018; status: completed.
Beyond the preview
Go deeper on NCT03421834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03421834.